BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) saw a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 5,039 shares, a decline of 52.6% from the November 30th total of 10,630 shares. Based on an average trading volume of 40 shares, the short-interest ratio is currently 126.0 days. Based on an average trading volume of 40 shares, the short-interest ratio is currently 126.0 days.
BICO Group AB (publ) Stock Performance
CLLKF stock opened at C$2.11 on Monday. The firm’s 50-day moving average price is C$2.21 and its two-hundred day moving average price is C$2.80. BICO Group AB has a 12-month low of C$1.97 and a 12-month high of C$4.21.
About BICO Group AB (publ)
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
Featured Stories
- Five stocks we like better than BICO Group AB (publ)
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- [No Brainer Gold Play]: “Show me a better investment.”
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
